FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds or their pharmaceutically acceptable salts which can be applicable for biologically active substances delivery.
EFFECT: invention refers to pharmaceutical formulations containing the above compounds, and to a method for administering the biologically active substances.
17 cl, 10 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS | 2005 |
|
RU2403237C2 |
| IMIDAZOPYRIDINE DERIVATIVE USED IN TREATMENT OF DIABETES | 2013 |
|
RU2648242C2 |
| ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
| SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS | 2016 |
|
RU2720488C2 |
| SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN | 2014 |
|
RU2669367C2 |
| AMINOISOQUINOLINE THROMBIN INHIBITOR WITH IMPROVED BIOAVAILABILITY | 2007 |
|
RU2437879C2 |
| DERIVATIVES OF CONDENSED 1,2,4-THIADIAZINE AND CONDENSED 1,4-THIAZINE, THEIR SYNTHESIS AND USING | 1997 |
|
RU2199542C2 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| METHODS, COMPOUNDS AND COMPOSITIONS FOR TREATING ANGIOTENSIN-ASSOCIATED DISEASES | 2014 |
|
RU2688163C2 |
| CONDENSED AROMATIC DIFLUOROMETHANE PHOSPHONATES AS PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) INHIBITORS | 2008 |
|
RU2462469C2 |
